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Recombination Phenotypes of Escherichia coli
greA Mutants
Anthony R Poteete
Abstract
Background: The elongation factor GreA binds to RNA polymerase and modulates transcriptional pausing. Some
recent research suggests that the primary role of GreA may not be to regulate gene expression, but rather, to
promote the progression of replication forks which collide with RNA polymerase, and which might otherwise
collapse. Replication fork collapse is known to generate dsDNA breaks, which can be recombinogenic. It follows
that GreA malfunction could have consequences affecting homologous recombination.
Results: Escherichia coli mutants bearing substitutions of the active site acidic residues of the transcription
elongation factor GreA, D41N and E44K, were isolated as suppressors of growth inhibition by a toxic variant of the
bacteriophage lambda Red-beta recombination protein. These mutants, as well as a D41A greA mutant and a greA
deletion, were tested for proficiency in recombination events. The mutations were found to increase the efficiency
of RecA-RecBCD-mediated and RecA-Red-mediated recombination, which are replication-independent, and to
decrease the efficiency of replication-dependent Red-mediated recombination.
Conclusion: These observations provide new evidence for a role of GreA in resolving conflicts between replication
and transcription.
Background
The GreA protein is an evolutionarily-conserved bacter-
ial transcriptional factor, which interacts directly with
RNA polymerase. Binding of GreA to paused and back-
tracked transcriptional complexes induces RNA poly-
merase to hydrolyze the last few nucleotide residues at
the 3’ end of the nascent transcript protruding beyond
the enzyme’s catalytic center, and resume transcription,
in vitro [1] and in vivo [2,3]. The extensively character-
ized interaction between RNA polymerase and GreA
leads most simply to the idea that GreA functions in
transcriptional regulation. Consistent with this idea, E.
coli lacking GreA protein exhibits altered levels of
expression of some of its genes [4,5], as well as of the
transcript encoding bacteriophage l proteins which are
synthesized late in infection [6]. However, the magni-
tude of the gene expression effects is small, and a clear
understanding of GreA’s biological function remains to
be obtained. Some recent studies have provided
evidence that GreA may have a role in resolving con-
flicts between replication and transcription [7,8].
In this study, greA mutants are shown to have effects
on homologous recombination which can be most read-
ily explained by a replication fork-preserving function of
wild type GreA. These mutants were isolated in a screen
for host functions which affect the cell’s interaction with
the Redb recombination protein of bacteriophage l.
In wild-type E. coli, homologous recombination
depends primarily on the function of two proteins, the
RecA synaptase and the RecBCD helicase/nuclease. For
genetic engineering purposes, RecBCD is often replaced
by the Red recombination system of bacteriophage l [9].
The Red system, consisting of the single-strand anneal-
ing protein Redb and the exonuclease lExo, can substi-
tute for RecBCD in promoting RecA-dependent
homologous recombination [10,11]. In addition, how-
ever, Red confers new capabilities on the cell, including
the ability of the cell’s chromosome to recombine with
short linear DNA species, even in the absence of RecA
[12,13]. In this RecA-independent mode of recombina-
tion, Red apparently acts by targeting the replisome,Correspondence: anthony.poteete@umassmed.edu
Department of Microbiology and Physiological Systems, University of
Massachusetts Medical School, Worcester, MA, USA
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leading to either strand assimilation or a template
switch [14,15].
Results
To probe interactions between the Red system and cel-
lular proteins, Redb was fused at its C-terminus to the
SPA affinity tag [16] on a medium copy number plas-
mid, under control of the lac repressor. Redb-SPA was
found to be toxic, inhibiting the growth of wild type
E. coli when induced. This toxicity is surprising, because
Redb itself is innocuous, and hundreds of non-toxic
SPA-tagged E. coli proteins have been made and charac-
terized [17]. One possible explanation is that the syn-
thetic toxicity of Redb-SPA results from the delivery of
the SPA tag to a critical site, possibly the normal site of
Redb action in the cell. As a hypothetical example, if
Redb normally binds to a replisome protein, it would
necessarily have evolved to do so without interfering
with replication. However, Redb with the 69 amino acid
residue SPA tag appended might bind to its normal site
and clash sterically with another component of the
replisome. According to this reasoning, cellular mutants
altered in their interaction with Redb could be selected
as suppressors of Redb-SPA toxicity. Several such sup-
pressor mutants were isolated. Initial mapping showed
that three of the mutations mapped to the same area in
the E. coli chromosome. Fine-structure mapping and
sequencing revealed that these three mutants each
encoded a GreA protein with a single amino acid substi-
tution: D41N (isolated twice), or E44K. The affected
residues are particularly significant in GreA’s activity.
Both participate in the coordination of Mg++ ions in the
catalytic core of RNA polymerase [18-20]. The greA-
D41N mutation was found not to affect the level of
either Redb-SPA or Redb as detected by western blot
(not shown), ruling out the simplest explanation–that
the greA mutants suppress the toxicity of Redb-SPA by
preventing its synthesis.
To study the unexpected relationship between GreA
and Red, E. coli strains were constructed bearing the
greA D41N and E44K mutations, as well as a D41A
mutation and a simple greA deletion, in a variety of
genetic backgrounds. The strains were found to have a
number of recombination-related phenotypes.
Consistent with the idea that the greA mutants might
be affected in their interaction with Red, l behaves as if
it had a mutation in either red gene (bet or exo), or
both, when infecting these mutant bacteria. A l red
gam double mutant does not form plaques on a recA
host, though red and gam single mutants do so [21]. As
indicated in Table 1, a l gam single mutant fails to
form plaques on a recA host when the recA host addi-
tionally bears a greA point mutation (but not a greA
deletion). A deletion eliminating both red genes reduces
l plaque size; similarly, the greA point mutations in the
host reduce the size of wild type l plaques. As might be
expected if mutating either red or greA is equivalent in
this test, the greA point mutations have less effect on
the plaque size of a l red mutant than on the plaque
size of l wild type. This latter observation suggests that
the greA point mutation primarily affects l red function,
rather than l transcription, but does not rule out the
possibility that there might be some effect on
transcription.
The effects of greA mutants on l recombination were
tested more directly in a marker rescue test, shown in
Figure 1. The crosses were done in a recA host, to
restrict recombination to the Red-promoted, replisome
invasion pathway [15]. Marker rescue was reduced 3-4
fold by the D41N and E44K substitutions, 2-fold by
D41A, and very slightly by the greA deletion. The effects
of the greA mutations on Red-mediated recombination
are modest compared to the effects of a red deletion
mutant, which reduces plaque formation in this test to
the background of reversion, approximately 40-fold
(data not shown).
The greA mutations also affect Red-mediated recombi-
nation outside the context of a phage infection. As
shown in Figure 2, the efficiency of recombination
between the bacterial chromosome and a linear dsDNA
introduced by electroporation is reduced in the greA
mutants, which exhibit the same rank order of effects as
in the marker rescue experiment.
Recombination via the RecA-RecBCD pathway is also
affected by greA mutations. P1 transduction of the Tn10
tetRA genes inserted into several different locations in
the chromosome was tested in the D41N mutant. In
most, but not all cases, the mutant gave rise to more
transductants than the wild type. A marker consisting of
the metB gene replaced by tetRA was typical. As shown
in Figure 3, the efficiency of transduction of metBΔtet is
elevated by all the greA mutations. Again, the rank
order of effects is the same, though in the opposite
direction. The elevated frequency of transduction in the
greA mutants could be attributed to an elevated
Table 1 l plaque formationa
Host genotypeb l wild l gam l red
wild type ++ + +
greA-D41N + - +
greA-D41A + - +
greA-E44K + - +
greAΔ ++ + +
greBΔ ++ + +
greBΔ greA-D41N + - +
a. ++ large plaques, + small plaques, - no plaques.
b. All strains bear a recAΔtet substitution.
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frequency of recombination, rather than to a greater
efficiency of P1 infection or tetRA expression, because
P1 transduction of tetRA at some other loci, for example
proAB or recA, was not elevated (data not shown).
To characterize further the specificity of greA recom-
bination effects, the effect of the greA-D41N mutation
on RecA-mediated recombination was tested in a strain
in which recBCD was replaced by red. As shown in
Figure 3, the replacement has little effect, in either a
GreA+ or a greA-D41N background. In particular, the
greA mutation stimulates RecA-Red recombination at least
as much as it stimulates RecA-RecBCD recombination.
The GreB protein of E. coli is very similar to GreA in
structure and biochemical activities [22]. The transcrip-
tional effects of a greA deletion mutant are often greater
in a strain in which greB is deleted as well [23,6,5,8].
However, as shown in Table 1 and Figures 1, 2, and 3,
deletion of greB had little or no effect on recombination,
either by itself or in combination with greA-D41N.
The DksA protein of E. coli, compared to GreB, is
more distantly related to GreA, but it shares a number
of structural and mechanistic features with the Gre pro-
teins, including an acid-tipped coiled coil which reaches
into the secondary channel of RNA polymerase to regu-
late transcription [24,25]. Chromosomal dksA mutants
corresponding to the greA mutants described above
were constructed and tested for recombination pheno-
types: a deletion fusing the first three and last three
codons, and a double substitution mutation neutralizing
both of the acid fingertip residues, D71N/D74N [24,26].
In contrast to the greA mutants, neither dksA mutant
exhibited either depressed or elevated levels of Red-
mediated or RecA-RecBCD-mediated recombination,
nor was either resistant to Redb-SPA (data not shown).
The mechanism by which the greA point mutations
suppress Redb-SPA toxicity was investigated by means
of a complementation test. Wild type, D41N, and E44K
alleles of greA, under control of their own promoters,
were cloned in multicopy plasmids which are compati-
ble with the Redb-SPA expressing plasmids. The wild
type greA plasmid was found to restore Redb-SPA sensi-
tivity to a chromosomal greA-D41N mutant, indicating
Figure 1 Marker rescue. A. l cI857 R-am5, bearing an amber mutation in the endolysin gene R, can form a plaque on the non-suppressing
host only if it recombines with the plasmid or reverts. B. Efficiencies of mutants relative to wild type. Titers of the phage on cells bearing the
homology-containing plasmid, minus titers on cells bearing the vector (revertants) are determined, and divided by the wild type value. Means
and standard errors of four experiments are shown. All strains are recA.
Figure 2 Red-mediated chromosomal gene replacement. A. Strains bearing an alteration of the lac locus in which lacI through the N-
terminal coding region of lacZ is replaced by the C-terminal two-thirds of the bla gene and the aph gene of Tn903 can recombine with a linear
dsDNA generated by PCR and introduced by electroporation, creating an ampicillin-resistant, Lac+ recombinant. B. Efficiencies of mutant strains
relative to wild type. Means and standard errors of three or four experiments are shown.
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that the suppression of Redb-SPA toxicity does not
result from a gain of function by the mutant GreA pro-
tein. Consistent with this conclusion, and more remark-
ably, the mutant plasmids do not confer Redb-SPA
resistance upon wild type E. coli, indicating that the
wild type phenotype prevails even when the mutant
gene has a higher copy number. However, interpretation
of this latter result is complicated because the mutant
plasmids significantly slow the growth of wild type cells,
as expected based on the known toxicity of the mutant
GreA proteins expressed at high levels [18].
The known biochemical properties of GreA substitu-
tion mutants suggest that one effect of the D41N or
E44K mutation would be to increase the amount of
time RNA polymerase spends stalled in certain back-
tracked transcriptional complexes. In the mutant, it is
likely that other cellular proteins which respond to
stalled transcriptional complexes will play a greater role
in resolving them. One such protein is Mfd, which not
only dissociates stalled transcription complexes, but at
the same time recruits proteins that repair DNA lesions
[27]. This line of reasoning leads to the question of
whether mutant GreA suppression of Redb-SPA toxicity
is mediated by Mfd. Accordingly, wild type and greA-
D41N strains lacking the mfd gene were constructed.
Deletion of mfd was found to have no effect on either
the Redb-SPA resistance of the D41N mutant, or the
Redb-SPA sensitivity of wild type. It can be concluded
that Mfd is not required for greA-D41N suppression of
Redb-SPA toxicity.
Discussion and Conclusions
The experiments described here show that E. coli greA
mutants exhibit elevated levels of RecA-mediated
recombination, and depressed levels of Red-mediated,
RecA-independent recombination. GreA is a transcrip-
tion factor, so these differing effects could be due to
changes in gene expression, but recombination and
DNA metabolism functions are not among the genes
identified as significantly up- or down-regulated in a
greA null mutant [5]. A more likely explanation comes
from the idea that GreA functions to prevent stalling of
replication forks that run into conflicts with transcrip-
tion complexes [7,8].
Replication in E.coli is highly processive, and main-
tains this processivity despite the presence on the tem-
plate DNA of transcription complexes which have an
intrinsic ability to stall replication forks [28]. Stalled
replication forks are a potentially dangerous source of
genetic instability, because they generate double-strand
breaks through a process of RuvABC-mediated reversal
and cleavage [29]. The dsDNA ends resulting from
these breaks are recombinogenic [30], so loss of a func-
tion which promotes the progression of replication forks
is predicted to stimulate RecA-RecBCD and RecA-Red
recombination events, which proceed via mechanisms
that are largely replication-independent [31]. Red-
mediated recombination in the absence of RecA, on the
other hand, is itself strongly replication-dependent
[15,32], so loss of a function which promotes the pro-
gression of replication forks might be expected to
diminish it.
The greA mutant phenotypes reported here are consis-
tent with a model in which replication forks stall either
more frequently or for a longer time in a cell in which
GreA is inactive. Replication processivity in the mutant
then becomes dependent upon other transcription-
replication mediators. A functionally defective GreA
protein, such as D41N or E44K, which can still bind to
its normal site on RNA polymerase, might have an
Figure 3 Transduction. Strains were infected with an amount of a P1 lysate grown on a metBΔtet strain sufficient to generate 50-100
transductants in the wild type. Ratios of mutant transductants to wild type transductants were calculated. Means and standard errors of 3-8
crosses are shown. A. RecBCD+ strains. B. Strains in which recBCD is replaced by red.
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exacerbated effect, by competing with one or more of
the other mediators.
Two recent studies present evidence for a role of
GreA in promoting the progression of replication forks.
(1) Deletion of greA increases the UV sensitivity of a
ruvC mutant. This effect of the greA mutant is
suppressed by the RNA polymerase open complex-
destabilizing rpoB mutant H1244Q. The investigators
also found that GreA and DksA together contribute to
the viability of a ruvC strain. They interpreted their
observations as indicating that these transcription fac-
tors act at DNA lesions to resolve conflicts between
DNA replication and transcription [7]. (2) Cultures of
an E. coli dnaC-ts mutant were synchronized by tem-
perature shift, then, after replication initiation, treated
with serine hydroxamate to induce amino acid starva-
tion. The treated cells completed the round of replica-
tion they had started, but failed to do so if they lacked
DksA, or if they lacked both GreA and GreB. The repli-
cation block could be eliminated by additional treatment
with rifampicin, or by a DksA-bypassing mutation in
rpoB, P546L, indicating that RNA polymerase was
responsible for the replication block, and that the tran-
scription factors affected replication through their well-
characterized interaction with RNA polymerase. The
replication deficiency of the dksA mutant in this experi-
ment could be complemented by overexpression of
GreA from a plasmid. In synchronized dnaC mutant
cells that were not treated with serine hydroxamate,
deletion of dksA slightly reduced the rate of replication
fork progression; deletion of dksA, greA, and greB all
together substantially reduced it. [8]. To these two lines
of evidence, a third is now added: in otherwise wild type
cells, not treated with DNA damaging agents or
metabolic inhibitors, greA mutations stimulate replica-
tion-independent recombination, and depress replica-
tion-dependent recombination.
Stimulation of replication-independent, RecA-
RecBCD-mediated recombination was not uniform, but
rather was found to vary among different loci. This
observation is consistent with the idea that the stimula-
tion is due to the production of dsDNA ends as a
byproduct of replication-transcription conflicts: such
conflicts would not be expected to occur at a uniform
frequency around the chromosome, because different
loci are transcribed at different rates.
Alteration of either of GreA’s key active site residues
has stronger recombination effects than simply eliminat-
ing GreA. This observation is consistent with previous
studies of many GreA mutants, including D41N and
D41A as well as other substitutions for both D41 and
E44. These mutants generally reduce or eliminate GreA-
induced transcript cleavage, but not binding to RNA
polymerase [18-20]. Unlike wild type GreA, the mutant
proteins inhibit elongation when used at high concen-
tration in vitro [18]. One unexplained observation of the
present study is that the D41A substitution was found
to have smaller effects on recombination than the D41N
substitution, whereas Laptenko et al. [18] found little if
any difference in biochemical activities between these
two mutants.
Wang and coworkers propose that the various tran-
scription-replication mediators, including DksA, GreA,
GreB and Mfd, could be specialized to prevent tran-
scription-replication conflict under different conditions
[8]. The experiments described here provide additional
support for this interpretation: based on the recombina-
tion and Redb-SPA sensitivity phenotypes, among these
proteins, only GreA appears to have a significant role in
mediating transcription-replication conflicts that arise
during rapid growth in rich medium. Some qualitative
observations on the growth properties of greA and dksA
mutants are also consistent with this idea. The greA
point mutants grow noticeably more slowly than either
wild type or the greA deletion on rich medium (LB), but
about as well as wild type on minimal medium (M9 glu-
cose-thiamine). In contrast, the dksA D71N/D74N
mutant grows about as well as wild type on LB, but only
a little better on M9 glucose-thiamine than the dksA
deletion mutant, which, as previously reported, grows
very poorly on minimal medium [33].
Methods
Strain construction
Redb was fused to the SPA affinity tag as described by
Zeghouf et al. [16], on plasmid pKM208 [34]. The
resulting plasmid, pTP1205, contains the lacI gene, a
synthetic operon in which l gam and redb-SPA are
transcribed from Ptac, and genes conferring resistance
to ampicillin (bla) and kanamycin (neo). A derivative,
pTP1206, was made by deleting bla. Further plasmid
construction details are given in Table 2. The growth of
wild type E. coli bearing pTP1205 or pTP1206, but not
pKM208, is inhibited by addition of the inducer isopro-
pyl-b-D-thiogalactoside (IPTG). For selection of Redb-
SPA-resistant mutants, the reduced-genome E. coli
strain MDS12 [35] was mutagenized with N-methyl-N’-
nitro-N-nitrosoguanidine plus chloramphenicol [36].
Plasmid pTP1206 was introduced into the mutagenized
cells by electroporation. Kanamycin- and IPTG-resistant
colonies were selected, and then screened, or re-
selected, for the ability to grow while bearing pTP1205
in the presence of IPTG.
Mapping of the Redb-SPA-resistant mutants was done
as described by Ortenberg et al. [37], except that the
mini transposon conferred resistance to tetracycline
instead of chloramphenicol. Each mutant was infected
with lNK1098 to generate a population with random
Poteete BMC Molecular Biology 2011, 12:12
http://www.biomedcentral.com/1471-2199/12/12
Page 5 of 10
tetracycline-resistant transposon insertions. Lysates of
phage P1 grown on the populations were used to trans-
duce wild type cells to tetracycline- and Redb-
SPA-resistance simultaneously. The mutation-linked
transposons were then located by the use of arbitrary PCR
and sequencing; oligonucleotides used for this purpose are
described in Table 3. The three greA mutants were first
localized to the vicinity of yrbD and yrbC. An argG::cat
insertion was then constructed, and three-factor crosses
were employed to determine that the location of the muta-
tions was between argG and yrbD (91% and 86% co-trans-
duction, respectively). Sequencing of the region revealed
that the three mutants had base substitutions altering greA
codons 41 (GAC to AAC, D41N, isolated twice indepen-
dently) or 44 (GAA to AAA, E44K), among other, uncor-
related mutations in nearby genes.
Mutations were introduced into the greA gene of
E. coli strain MG1655 by the use of Red-mediated recom-
bination, in a two-step process. The first two bases of
codon 41 or 44 were replaced with a tetracycline-
resistance cassette. Oligonucleotides were then used to
delete the cassette and insert the new bases [9]. Recombi-
nants were identified following kanamycin enrichment for
tetracycline-sensitives; details of the protocol are given
below. A deletion allele fusing the first three and last three
codons of greA was constructed the same way. The greA
alleles were verified by sequencing. The same processes
were used to construct chromsomal dksA-D71N/D74K
and dksA deletion mutants, except that the initial con-
struction replaced ten bases in codons 71-74 with the cat
gene. The greB mutation used in some of the experiments
was introduced by P1 transduction as greBΔkan-FRT; the
kanamycin resistance element in it was subsequently
excised by the use of FLP recombinase as described [38].
The mfd gene was deleted the same way. Other genetic
markers were introduced into greA, greB, or dksA mutant
strains by P1 transduction. Further strain construction
details are given in Table 4.
Kanamycin enrichment for chloramphenicol-sensitive or
tetracycline-sensitive variants
Following electroporation, bacteria were diluted into
15 ml of LB, and left standing overnight at 30°C for
complete recovery from electroporation and outgrowth
of fully sensitive recombinants. 0.2 ml of the culture was
diluted into 5 ml LB and aerated at 37°C until a density
of about 7 × 107/ml was reached. At that point, 2.5 ml
of culture was mixed with 2.5 ml LB plus 100 μl of
either chloramphenicol at 1 mg/ml or tetracycline at
0.4 mg/ml, and aerated at 37°C for 40 min. At that
time, 2 ml of culture was mixed with 2 ml LB plus 40 μl
chloramphenicol or tetracycline, plus 4 μl kanamycin at
20 mg/ml (for a final kanamycin concentration of
20 μg/ml), and aerated at 37°C for 40 min, then left stand-
ing overnight at room temperature. Portions of the culture
were plated on LB, and the resulting colonies were tested
for chloramphenicol or tetracycline sensitivity. Clones
bearing the intended deletion were identified by the use of
PCR and sequencing.
Phages
lNK1098 bears the mutations cI857 and P-am80, as
well as a mini Tn10 tet element and the Tn10 transpo-
sase fused to Ptac. It is similar to lNK1323 [39], but its
transposase is wild type, rather than the Altered Target
Specificity double mutant version borne by lNK1323.
The amber mutation R5 [40], used in marker rescue
Table 2 Plasmids
pCP20 [45]. Temperature-sensitive, with heat-inducible FLP
pKM208 [34]. bla-Ptac-gam-bet-exo-lacI, temperature-sensitive
mutant pSC101 origin
pJL148 [16]. SPA-neo
pTP1068 Plasmid containing bla-P32-aacC. See the description of
pTP1232 below.
pTP1205 pKM208 × SP01,02 pcr of pJL148. The Red-mediated
recombination event fuses the SPA tag to the C-
terminal end of bet, deletes most of exo, and adds
neo.
pTP1206 Deletion of bla from pTP1205 by digestion with PvuI
and religation
pTP1214 pKM208 × cat29,30 pcr of Tn9 cat. The Red-mediated
recombination event replaces a segment of pKM208
between lacI and the replication origin with the cat
gene, flanked by BamH1 sites.
pTP1215 Deletion of cat from pTP1214 by digestion with
BamH1 and religation
pTP1216 pTP1215 × cat27,28 pcr of Tn9 cat. The Red-mediated
recombination event replaces bla and the f1
replication origin with cat. Smaller, chloramphenicol
resistance-conferring version of pKM208.
pTP1222 A segment of l wild type DNA was amplified by SR2,3
pcr. The product was digested with BamH1 and XbaI,
and ligated with a BamH1- and XbaI-ended plasmid
segment consisting of the Tn903 aph gene and the
pSC101 replication origin.
pTP1223 Deletion of sequences between the EcoRV and XbaI
sites of pTP1222. The resulting plasmid contains l
sequences from 45262 in the S gene to 45828 in the R
gene.
pTP1228, 1230,
1231
Wild type, D41N, and E44K alleles of greA, respectively,
amplified by PCR with primers greA5 and greA6, and
cloned between the EcoR1 and BamH1 sites of a
derivative of pBR322 lacking the sequences between
the BamH1 and PvuII sites.
pTP1232 Contains the sequences used to construct TP1234,
DNA from which in turn was used as the template for
PCR synthesis of the 587-bp dsDNA used in the tests
of Red-mediated chromosomal gene replacement
(sequence shown in Figure 4). It includes the bla gene
of pBR322, the synthetic, unregulated promoter P32
(closely related to CP32 [46]), the lacZ ribosome
binding site, and the N-terminal end of lacZ.
Poteete BMC Molecular Biology 2011, 12:12
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experiments, was sequenced and found to change l
45710 from G-C to A-T, which turns R codon 73, UGG,
into UAG. The g210 mutation [21], used in plating tests,
was sequenced and found to change l 33076 from G-C
to A-T, which turns gam codon 53, CAG, into UAG.
The deletion-substitution mutation redΔcat, used in
plating tests, was constructed by the use of Red-
mediated recombination [41], with a dsDNA made by
PCR amplification of Tn9 cat with oligo primers cat38
and cat39 (Table 3). The deletion-substitution leaves in
place the first three codons of bet and the last three
codons of exo.
Gene-replacement recombination test
Strains to be tested for Red-mediated chromosomal
gene replacement were transformed with plasmid
pTP1216, a derivative of pKM208 in which bla is
replaced by cat. They were grown at 30°C in LB broth
Table 3 Oligos
aof2 TCCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTTAGGTGGCGGTACTTGGGT
ARB1a GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT
ARB2a GGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC
ARB6a GGCCACGCGTCGACTAGTAC
bpa TCTGGTGGCCGGAAGGCGAAGCGGCATGCATTTACGTTGAGGTCTGACAGTTACCAATGC
BLZ3 GAACTTTAAAAGTGCTCATCATTG
BLZ4 GGGTTTTCCCAGTCACG
cat27 TCGGAGATCCCCCGGGCTGCAGGAATTCGATATCAAGCTTATGAGACGTTGATCGGCACG
cat28 AGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTCAGGCGTAGCACCAGGC
cat29 GACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGGATCCATGAGACGTTGATCGGCACG
cat30 TGGCTAAATACGGAAGGATCTGAGGTTCTTATGGCTCTTGGATCCATTCAGGCGTAGCACCAGGC
cat34 TCAAAATCGTCAACCCGATTATGGGCGTGAAATTCTGGGAATGAGACGTTGATCGGCACG
cat35 GCGTACTGTGACTTCTTCTGCCGGGATCTTCACGCTCTCAATTCAGGCGTAGCACCAGGC
cat38 AGGTTGATATTGATTCAGAGGTATAAAACGAATGAGTACTATGAGACGTTGATCGGCACG
cat39 CCTACCCGGATATTATCGTGAGGATGCGTCATCGCCATTGATTCAGGCGTAGCACCAGGC
cat40 CACCGTTACACATATGCAGGATGAAGCAGCCAACTTCCCGATGAGACGTTGATCGGCACG
cat41 CGCAGTTCGAGGCTGAACTCTTCTTCCTGGGCTGCACGGTATTCAGGCGTAGCACCAGGC
D41A AGCTGCGTGGTATTCGGCGTTTTCTTTCAGGGCGCCATGCTCACGCGCTTCCGCGATAGCAGCAA
D41N AGCTGCGTGGTATTCGGCGTTTTCTTTCAGGTTGCCATGCTCACGCGCTTCCGCGATAGCAGCAA
dksAD AGTGCGTGTTAAGGAGAAGCAACATGCAAGAAATGGCTGGCTAATTACAGCCGTTCCATCACGT
dksNN CATATGCAGGATGAAGCAGCCAACTTCCCGAACCCGGTAAACCGTGCAGCCCAGGAAGAAGAGTTCAGCC
E44K CTGTTCACGAGCTGCGTGGTATTCGGCGTTTTTTTTCAGGTCGCCATGCTCACGCGCTTCCGCGA
greA5 CATCATCATGAATTCAGCTGGTCAATCCGATGA
greA6 ACTACTACTGGATCCTGTACAGGTCATCGGTAAAACG
greA9 TGAAATCATTGCTGCTATCGCGGAAGCGCGTGAGCATGGCCTCGACATCTTGGTTACCGT
greAD ACATCTTGAGTATTGGGTAATTCTTACAGGTATTCAGCTTGCATTTGTTATACCTCTTGAATATTCCTGA
greAX CTGTTCACGAGCTGCGTGGTATTCGGCGTTTTCTTTCAGGCGCGGAATAACATCATTTGG
greAY GCTGCTATCGCGGAAGCGCGTGAGCATGGCGACCTGAAAGCTCGACATCTTGGTTACCGT
greAZ AGAAACCCTGCTGTTCACGAGCTGCGTGGTATTCGGCGTTCGCGGAATAACATCATTTGG
PRO1 TGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTACAACCAATTAACCAATTCTG
PRO2 GTCACGACGTTGTAAAACGACGGCCAGTGAATCCGTAATCACGTTGTGTCTCAAAATCTC
Rtet1a CCACTTAATGTGATCATTGAACC
Rtet2a AACCATTTTCAGTGATCCATTGC
SP01 ATTCCTGAAACAGAAAGCCGCAGAGCAGAAGGTGGCAGCATCCATGGAAAAGAGAAG
SP02 TTGCTCCCCAAATACAAAACCAATTTCAGCCAGTGCCTCGCATATGAATATCCTCCTTAG
SR2 GACTACGACTACATCTAGATTCGAACATCGATATGGGCAACTCTATC
SR3 ATCAGCCATCATGGATCCGTTTGCAATGGCGTACCTT
a. Arbitrary PCR and sequencing to locate transposon insertions was done as described [47], but with primers designed for Tn10d(tet). The first round of PCR was
done with primers Rtet1, ARB1, and ARB6; the second with Rtet2 and ARB2. Sequencing was done with Rtet2.
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Table 4 Strains
MG1655 Wild type [43]
MDS12 Reduced genome version of MG1655 [35]
JW1100 mfdΔkanFRT [38]
JW3369 greBΔkanFRT [38]
TP796 MDS12 recAΔtet [44]
TP798 MG1655 recBCDΔPtac-gam-bet-exo-cat [44]
Strains constructed for this study. All are in the MG1655 background
TP933 recBCDΔPtac-gam-bet-exo-cat lacIPΔ::bla-P32-aacC-lacZ TP798 × bpa1,aof2 pcr of pTP1068
TP965 recBCDΔPtac-gam-bet-exo-cat lacIPΔbla’-kan-’lacZ TP933 × PRO1,2 pcr of Tn903 aph
TP1195 greA::tet41 MG1655/pKM208 × greA9,X pcr of Tn10 tet
TP1198 greA-D41N TP1195/pKM208 × oligo D41N
TP1201 recAΔtet MG1655 × P1•TP796
TP1202 greA-D41N recAΔtet TP1198 × P1•TP796
TP1203 greA::tet44 MG1655/pKM208 × greAY,Z pcr of Tn10
TP1204 greA-D41A TP1195/pKM208 × oligo D41A
TP1205 greAΔ TP1195/pKM208 × oligo greAD
TP1208 greA-D41A recAΔtet TP1204 × P1•TP796
TP1209 greAΔ recAΔtet TP1205 × P1•TP796
TP1213 greAΔ greBΔtet TP1205 × P1•TP1199
TP1216 greA-E44K TP1203/pKM208 × oligo E44K
TP1218 greBΔkanFRT MG1655 × P1•JW3369
TP1219 greA-E44K recAΔtet TP1216 × P1•TP796
TP1220 greA-E44K greBΔtet TP1216 × P1•TP1199
TP1222 greBΔFRT TP1218/pCP20 passaged at 42°
TP1224 greA-D41N greBΔkanFRT TP1198 × P1• JW3369
TP1225 lacIPΔbla’-kan-’lacZ MG1655 × P1•TP965
TP1226 greA-D41N lacIPΔbla’-kan-’lacZ TP1198 × P1•TP965
TP1227 greA-D41A lacIPΔbla’-kan-’lacZ TP1204 × P1•TP965
TP1229 greA-E44K lacIPΔbla’-kan-’lacZ TP1216 × P1•TP965
TP1230 recBCDΔred-cat greA-D41N TP1198 × P1•TP798
TP1231 greA-D41N greBΔFRT TP1224/pCP20 passaged at 41°
TP1232 greBΔFRT lacIPΔbla’-kan-’lacZ TP1222 × P1•TP965
TP1233 greA-D41N greBΔFRT lacIPΔbla’-kan-’lacZ TP1231 × P1•TP965
TP1234 lacIPΔ::bla-P32 TP1225/pTP1216 × pTP1232 linear
TP1235 greBΔFRT recAΔtet TP1222 × P1•TP796
TP1236 greA-D41N greBΔFRT recAΔtet TP1231 × P1•TP796
TP1241 greAΔcat lacIPΔbla’-kan-’lacZ TP1193 × P1•TP965
TP1242 greAΔ lacIPΔbla’-kan-’lacZ TP1205 × P1•TP965
TP1252 mfdΔkanFRT MG1655 × P1•JW1100
TP1253 greA-D41N mfdΔkanFRT TP1198 × P1•JW1100
TP1254 greA-E44K mfdΔkanFRT TP1216 × P1•JW1100
TP1255 dksAΔ10::cat MG1655/pKM208 × cat40,41 pcr of Tn9
TP1257 mfdΔFRT TP1252/pCP20 passaged at 41°
TP1258 greA-D41N mfdΔFRT TP1253/pCP20 passaged at 41°
TP1259 greA-E44K mfdΔFRT TP1254/pCP20 passaged at 41°
TP1260 dksA-D71N/D74N TP1255/pKM208 × oligo dksNN
TP1262 dksA-D71N/D74N recAΔtet TP1262 × P1•TP796
TP1263 dksAΔ TP1255/pKM208 × oligo dksAD
TP1264 dksAΔ recAΔtet TP1263 × P1•TP796
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supplemented with chloramphenicol at 20 μg/ml,
induced with 1 mM IPTG, and prepared for electro-
poration as described by Murphy and Campellone [34].
Cells were electroporated with a mixture of 150 ng of
a dsDNA generated by PCR of plasmid pTP1232
(Table 2) with oligo primers BLZ3 and BLZ4 (Table 3),
plus 1 ng of plasmid pMB9 [42]. The linear dsDNA was
587 bp, including 50 bp homology-targeting flanks
(Figure 4). Following electroporation, the cells were
diluted into 3 ml LB broth, grown with aeration for 2 hr
at 37°C, and plated at 37°C on LB agar supplemented
with ampicillin at 100 μg/ml, or tetracycline at 15 μg/ml.
To adjust for variable growth rates and electroporation
efficiencies, the ratio of ampicillin-resistant (recombi-
nant) to tetracycline-resistant (transformant) colonies,
normalized to that of the wild type control, was used as a
measure of relative recombination proficiency.
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